PortfoliosLab logoPortfoliosLab logo
PHIO vs. CPRT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PHIO vs. CPRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Phio Pharmaceuticals Corp. (PHIO) and Copart, Inc. (CPRT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PHIO achieves a 6.67% return, which is significantly higher than CPRT's -21.17% return. Over the past 10 years, PHIO has underperformed CPRT with an annualized return of -68.82%, while CPRT has yielded a comparatively higher 17.60% annualized return.


PHIO

1D
-0.88%
1M
-1.75%
YTD
6.67%
6M
-8.94%
1Y
-45.37%
3Y*
-66.60%
5Y*
-65.65%
10Y*
-68.82%

CPRT

1D
-4.52%
1M
-7.24%
YTD
-21.17%
6M
-20.79%
1Y
-39.25%
3Y*
-11.16%
5Y*
-0.03%
10Y*
17.60%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PHIO vs. CPRT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PHIO
Phio Pharmaceuticals Corp.
6.67%-41.67%-73.68%-82.97%-62.80%-62.83%-71.40%-48.17%-94.07%-22.21%
CPRT
Copart, Inc.
-21.17%-31.78%17.12%60.95%-19.68%19.15%39.93%90.33%10.63%55.89%

Correlation

The correlation between PHIO and CPRT is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.11

Correlation (All Time)
Calculated using the full available price history since May 11, 2012

0.11

The correlation between PHIO and CPRT shifts across timeframes, from 0.07 (3 years) to 0.17 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PHIO:

$13.01M

CPRT:

$29.79B

EPS

PHIO:

-$1.31

CPRT:

$1.59

PB Ratio

PHIO:

0.79

CPRT:

3.39

Total Revenue (TTM)

PHIO:

$0.00

CPRT:

$4.64B

Gross Profit (TTM)

PHIO:

-$1.08M

CPRT:

$2.11B

EBITDA (TTM)

PHIO:

-$7.23M

CPRT:

$2.00B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PHIO vs. CPRT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PHIO
PHIO Risk / Return Rank: 2020
Overall Rank
PHIO Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
PHIO Sortino Ratio Rank: 2020
Sortino Ratio Rank
PHIO Omega Ratio Rank: 2121
Omega Ratio Rank
PHIO Calmar Ratio Rank: 1818
Calmar Ratio Rank
PHIO Martin Ratio Rank: 2222
Martin Ratio Rank

CPRT
CPRT Risk / Return Rank: 11
Overall Rank
CPRT Sharpe Ratio Rank: 00
Sharpe Ratio Rank
CPRT Sortino Ratio Rank: 11
Sortino Ratio Rank
CPRT Omega Ratio Rank: 22
Omega Ratio Rank
CPRT Calmar Ratio Rank: 00
Calmar Ratio Rank
CPRT Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PHIO vs. CPRT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Phio Pharmaceuticals Corp. (PHIO) and Copart, Inc. (CPRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PHIOCPRTDifference

Sharpe ratio

Return per unit of total volatility

-0.53

-1.67

+1.14

Sortino ratio

Return per unit of downside risk

-0.46

-2.46

+1.99

Omega ratio

Gain probability vs. loss probability

0.95

0.70

+0.24

Calmar ratio

Return relative to maximum drawdown

-0.62

-1.01

+0.39

Martin ratio

Return relative to average drawdown

-0.91

-1.80

+0.88

PHIO vs. CPRT - Sharpe Ratio Comparison

The current PHIO Sharpe Ratio is -0.53, which is higher than the CPRT Sharpe Ratio of -1.67. The chart below compares the historical Sharpe Ratios of PHIO and CPRT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PHIOCPRTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.53

-1.67

+1.14

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.36

-0.00

-0.36

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.46

0.64

-1.10

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.25

0.48

-0.73

Drawdowns

PHIO vs. CPRT - Drawdown Comparison

The maximum PHIO drawdown since its inception was -100.00%, which is greater than CPRT's maximum drawdown of -72.49%. Use the drawdown chart below to compare losses from any high point for PHIO and CPRT.


Loading charts...

Drawdown Indicators


PHIOCPRTDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-72.49%

-27.51%

Max Drawdown (1Y)

Largest decline over 1 year

-71.05%

-39.50%

-31.55%

Max Drawdown (3Y)

Largest decline over 3 years

-97.15%

-51.66%

-45.49%

Max Drawdown (5Y)

Largest decline over 5 years

-99.67%

-51.66%

-48.01%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-51.66%

-48.34%

Current Drawdown

Current decline from peak

-100.00%

-51.66%

-48.34%

Average Drawdown

Average peak-to-trough decline

-91.33%

-16.54%

-74.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

48.14%

22.27%

+25.87%

Volatility

PHIO vs. CPRT - Volatility Comparison

Phio Pharmaceuticals Corp. (PHIO) has a higher volatility of 11.39% compared to Copart, Inc. (CPRT) at 8.73%. This indicates that PHIO's price experiences larger fluctuations and is considered to be riskier than CPRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PHIOCPRTDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.39%

8.73%

+2.66%

Volatility (6M)

Calculated over the trailing 6-month period

64.55%

18.59%

+45.96%

Volatility (1Y)

Calculated over the trailing 1-year period

86.33%

23.57%

+62.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

183.79%

25.94%

+157.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

150.20%

27.43%

+122.77%

Dividends

PHIO vs. CPRT - Dividend Comparison

Neither PHIO nor CPRT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PHIO vs. CPRT - Financials Comparison

This section allows you to compare key financial metrics between Phio Pharmaceuticals Corp. and Copart, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B202220232024202520260
1.24B
(PHIO) Total Revenue
(CPRT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PHIO and CPRT have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PHIO has higher volatility (11.39%) compared to CPRT (8.73%). In terms of maximum drawdown, PHIO dropped -100.00% vs CPRT's -72.49%.

PHIO currently has the higher Sharpe Ratio (-0.53 vs -1.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PHIO and CPRT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer